The androgen receptor amino-terminal domain: structure, function and therapeutic potential
Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes up more than half of the protein and has been found to be intrinsically disordered. This structural plasticity mediates receptor-dependent tra...
Saved in:
| Published in | Endocrine oncology Vol. 5; no. 1; p. e240061 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Bioscientifica Ltd
01.01.2025
Bioscientifica |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes up more than half of the protein and has been found to be intrinsically disordered. This structural plasticity mediates receptor-dependent transcription, intradomain interactions and allosteric regulation. AR activity is a primary drug target in advanced and metastatic prostate cancer, a leading cause of cancer-related death in men. Recent research has focused on the amino-terminal domain as a novel drug target. In this review, we discuss the structural properties of the receptor and highlight some promising preclinical and clinical studies that aim to develop a drug discovery pipeline of small-molecule inhibitors targeting the amino-terminal domain. |
|---|---|
| AbstractList | Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes up more than half of the protein and has been found to be intrinsically disordered. This structural plasticity mediates receptor-dependent transcription, intradomain interactions and allosteric regulation. AR activity is a primary drug target in advanced and metastatic prostate cancer, a leading cause of cancer-related death in men. Recent research has focused on the amino-terminal domain as a novel drug target. In this review, we discuss the structural properties of the receptor and highlight some promising preclinical and clinical studies that aim to develop a drug discovery pipeline of small-molecule inhibitors targeting the amino-terminal domain. Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes up more than half of the protein and has been found to be intrinsically disordered. This structural plasticity mediates receptor-dependent transcription, intradomain interactions and allosteric regulation. AR activity is a primary drug target in advanced and metastatic prostate cancer, a leading cause of cancer-related death in men. Recent research has focused on the amino-terminal domain as a novel drug target. In this review, we discuss the structural properties of the receptor and highlight some promising preclinical and clinical studies that aim to develop a drug discovery pipeline of small-molecule inhibitors targeting the amino-terminal domain.Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes up more than half of the protein and has been found to be intrinsically disordered. This structural plasticity mediates receptor-dependent transcription, intradomain interactions and allosteric regulation. AR activity is a primary drug target in advanced and metastatic prostate cancer, a leading cause of cancer-related death in men. Recent research has focused on the amino-terminal domain as a novel drug target. In this review, we discuss the structural properties of the receptor and highlight some promising preclinical and clinical studies that aim to develop a drug discovery pipeline of small-molecule inhibitors targeting the amino-terminal domain. |
| Author | Hunter, Irene Jamieson, Craig McEwan, Iain J |
| AuthorAffiliation | 1 Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus , Aberdeen , UK 2 Department of Pure and Applied Chemistry, University of Strathclyde , Glasgow , UK |
| AuthorAffiliation_xml | – name: 2 Department of Pure and Applied Chemistry, University of Strathclyde , Glasgow , UK – name: 1 Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus , Aberdeen , UK |
| Author_xml | – sequence: 1 givenname: Irene orcidid: 0000-0003-0165-4359 surname: Hunter fullname: Hunter, Irene organization: Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus, Aberdeen, UK – sequence: 2 givenname: Craig orcidid: 0000-0002-6567-8272 surname: Jamieson fullname: Jamieson, Craig organization: Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK – sequence: 3 givenname: Iain J orcidid: 0000-0003-2087-0663 surname: McEwan fullname: McEwan, Iain J organization: Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus, Aberdeen, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40051657$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVkUtv1DAUhS1URB90ww9AWSJEwG8nbBCqplCp0mzKho11Y9_MuErs4DhI_HsyTKna1bF8j79zrXNOTmKKSMgbRj8yJeinzbbmsqZUsxfkjGsha2lacfLkfEou5_meUsobwxutX5FTSaliWpkz8vNujxVEn9MOY5XR4VRSrmAMMdUF86owVD6NEOLnai55cWXJ-KHql-hKSPHwuCp7zDDhUoKrplQwlgDDa_Kyh2HGywe9ID-uN3dX3-vb7bebq6-3teOyZbWSwnS-BYNCQS9dx4xXHetX0Uow6XoORnWmE9CCBIEd01oLxZTjvfFGXJCbI9cnuLdTDiPkPzZBsP8uUt5ZyOtmA1rWGO-kELTvuKSNbHvvnVFolGLcde3K-nJkTUs3onfrTzIMz6DPJzHs7S79tow1jWi0XAnvHgg5_VpwLnYMs8NhgIhpma1gRjacc9qs1rdPwx5T_rezGt4fDS6nec7YP1oYtYf27WZrubSH9sVf5Juh3A |
| ContentType | Journal Article |
| Copyright | the author(s). the author(s) 2025 the author(s) |
| Copyright_xml | – notice: the author(s). – notice: the author(s) 2025 the author(s) |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1530/EO-24-0061 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2634-4793 |
| ExternalDocumentID | oai_doaj_org_article_187dc4330fb240849fddc75e75512cb9 PMC11883864 40051657 10_1530_EO_24_0061 |
| Genre | Journal Article Review |
| GroupedDBID | 53G AAFZV AAKMT AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION EBS GROUPED_DOAJ M~E PGMZT RPM TBS NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c2491-5437bd9a7e35af4cb17d5b1f17d65314cf2a75b7b3a9a4a3eb16663515c2f7d73 |
| IEDL.DBID | DOA |
| ISSN | 2634-4793 |
| IngestDate | Wed Aug 27 01:31:29 EDT 2025 Thu Aug 21 18:33:51 EDT 2025 Fri Jul 11 08:19:14 EDT 2025 Mon Jul 21 05:59:27 EDT 2025 Wed Aug 27 16:27:19 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | endocrine therapy resistance prostate androgen receptor |
| Language | English |
| License | the author(s). This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2491-5437bd9a7e35af4cb17d5b1f17d65314cf2a75b7b3a9a4a3eb16663515c2f7d73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-2087-0663 0000-0002-6567-8272 0000-0003-0165-4359 |
| OpenAccessLink | https://doaj.org/article/187dc4330fb240849fddc75e75512cb9 |
| PMID | 40051657 |
| PQID | 3174822208 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_187dc4330fb240849fddc75e75512cb9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11883864 proquest_miscellaneous_3174822208 pubmed_primary_40051657 crossref_primary_10_1530_EO_24_0061 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-Jan |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-Jan |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Bristol |
| PublicationTitle | Endocrine oncology |
| PublicationTitleAlternate | Endocr Oncol |
| PublicationYear | 2025 |
| Publisher | Bioscientifica Ltd Bioscientifica |
| Publisher_xml | – name: Bioscientifica Ltd – name: Bioscientifica |
| References | Emenecker RJ (bib20) 2021; 120 Christiaens V (bib13) 2002; 277 Bevan CL (bib6) 1999; 19 De Mol E (bib16) 2016; 11 Yu X (bib64) 2020; 79 Shaffer PL (bib52) 2004; 101 Basu S (bib5) 2023; 30 Henry MC (bib27) 2023; 14 Reid J (bib47) 2002a; 277 Liu C (bib70) 2014; 20 He B (bib25) 2004; 16 Lavery DN (bib33) 2008; 47 Dubbink HJ (bib18) 2004; 18 McEwan IJ (bib39) 1997; 94 Thiyagarajan T (bib56) 2023; 120 Hnisz D (bib29) 2017; 169 Chen QH (bib12) 2014; 16 Wu M (bib59) 2023; 12 Estébanez-Perpiñá E (bib23) 2021; 13 Reid J (bib48) 2002b; 277 Sheikhhassani V (bib53) 2022; 31 McEwan IJ (bib38) 2021 Hirayama Y (bib28) 2020; 14 De Mol E (bib17) 2018; 26 Bielskutė S (bib7) 2021; 30 Jenster G (bib30) 1995; 270 He Y (bib26) 2021; 64 Banuelos CA (bib4) 2020; 12 Davies P (bib14) 2008; 41 Dehm SM (bib15) 2008; 68 Spada ARL (bib54) 1991; 352 Liu C (bib36) 2016; 7 Tan MHE (bib55) 2015; 36 Zhu J (bib69) 2022; 13 Bouchard JJ (bib8) 2018; 72 Laccetti AL (bib32) 2023; 41 Simental JA (bib51) 1991; 266 van Royen ME (bib57) 2007; 177 Meyer S (bib40) 2016; 10 Bray F (bib9) 2018; 68 Roggero CM (bib50) 2022; 17 Hay CW (bib24) 2012; 7 Monaghan AE (bib41) 2022; 20 Myung JK (bib42) 2013; 123 Estébanez-Perpiñá E (bib22) 2007; 104 Riley CM (bib49) 2023; 43 Andersen RJ (bib2) 2010; 17 Nadal M (bib43) 2017; 8 Martin SK (bib37) 2014; 9 Cato L (bib10) 2017; 6 Zhang F (bib67) 2023b; 51 Xie J (bib61) 2022; 18 Yi P (bib62) 2017; 67 Dunker AK (bib19) 2001; 19 Narayanan R (bib44) 2021; 20 Liu GZ (bib35) 2003; 278 Liang Q (bib34) 2024; 43 Asangani IA (bib3) 2014; 510 Yi Q (bib63) 2023; 22 Yu X (bib65) 2022; 25 Xiao M (bib60) 2024; 67 Zhang B (bib66) 2023a; 66 Kang CB (bib31) 2019; 20 Ahmed J (bib1) 2021; 30 Eftekharzadeh B (bib21) 2016; 110 Varadi M (bib58) 2024; 52 Zhu P (bib68) 2006; 124 Chen CD (bib11) 2004; 10 Parikh M (bib45) 2021; 11 Ponnusamy S (bib46) 2019; 25 |
| References_xml | – volume: 123 start-page: 2948 year: 2013 ident: bib42 article-title: An androgen receptor N-terminal domain antagonist for treating prostate cancer – volume: 43 start-page: 1898 year: 2024 ident: bib34 article-title: MolPhase, an advanced prediction algorithm for protein phase separation – volume: 13 start-page: 509 year: 2021 ident: bib23 article-title: Eighty years of targeting androgen receptor activity in prostate cancer: the fight goes on – volume: 67 start-page: 5567 year: 2024 ident: bib60 article-title: Structure-activity relationship (SAR) studies of novel monovalent AR/AR-V7 dual degraders with potent efficacy against advanced prostate cancer – volume: 270 start-page: 7341 year: 1995 ident: bib30 article-title: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor – volume: 25 start-page: 6764 year: 2019 ident: bib46 article-title: Orally bioavailable androgen receptor degrader, potential next-generation therapeutic for enzalutamide-resistant prostate cancer – volume: 67 start-page: 733 year: 2017 ident: bib62 article-title: Structural and functional impacts of ER coactivator sequential recruitment – volume: 120 year: 2023 ident: bib56 article-title: Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer – volume: 9 start-page: 628 year: 2014 ident: bib37 article-title: N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy – volume: 124 start-page: 615 year: 2006 ident: bib68 article-title: Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway – volume: 510 start-page: 278 year: 2014 ident: bib3 article-title: Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer – volume: 10 start-page: 175 year: 2016 ident: bib40 article-title: Backbone 1H, 15N, 13C NMR assignment of the 518-627 fragment of the androgen receptor encompassing N-terminal and DNA binding domains – volume: 20 start-page: 111 year: 2022 ident: bib41 article-title: Development of a high-throughput screening assay for small-molecule inhibitors of androgen receptor splice variants – volume: 7 start-page: 32210 year: 2016 ident: bib36 article-title: Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer – volume: 52 start-page: D368 year: 2024 ident: bib58 article-title: AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences – volume: 19 start-page: 8383 year: 1999 ident: bib6 article-title: The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1 – volume: 36 start-page: 3 year: 2015 ident: bib55 article-title: Androgen receptor: structure, role in prostate cancer and drug discovery – volume: 30 start-page: 1427 year: 2021 ident: bib7 article-title: Low amounts of heavy water increase the phase separation propensity of a fragment of the androgen receptor activation domain – volume: 104 start-page: 16074 year: 2007 ident: bib22 article-title: A surface on the androgen receptor that allosterically regulates coactivator binding – volume: 177 start-page: 63 year: 2007 ident: bib57 article-title: Compartmentalization of androgen receptor protein-protein interactions in living cells – volume: 12 year: 2023 ident: bib59 article-title: Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer – volume: 68 start-page: 5469 year: 2008 ident: bib15 article-title: Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance – volume: 14 start-page: 2455 year: 2020 ident: bib28 article-title: Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer – volume: 51 start-page: 99 year: 2023b ident: bib67 article-title: Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression – volume: 277 start-page: 49230 year: 2002 ident: bib13 article-title: Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control – volume: 11 start-page: 6377 year: 2021 ident: bib45 article-title: Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer – volume: 68 start-page: 394 year: 2018 ident: bib9 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries – volume: 17 year: 2022 ident: bib50 article-title: Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity – volume: 8 year: 2017 ident: bib43 article-title: Structure of the homodimeric androgen receptor ligand-binding domain – volume: 12 start-page: 1991 year: 2020 ident: bib4 article-title: Ralaniten sensitizes enzalutamide-resistant prostate cancer to ionizing radiation in prostate cancer cells that express androgen receptor splice variants – volume: 79 start-page: 812 year: 2020 ident: bib64 article-title: Structural insights of transcriptionally active, full-length androgen receptor coactivator complexes – volume: 16 start-page: 425 year: 2004 ident: bib25 article-title: Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance – volume: 20 start-page: 139 year: 2019 ident: bib31 article-title: Applications of in-cell NMR in structural biology and drug discovery – volume: 20 start-page: 3198 year: 2014 ident: bib70 article-title: Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer – volume: 41 start-page: 179 year: 2023 ident: bib32 article-title: Phase 1/2 study of EPI-7386 in combination with enzalutamide (enz) compared with enz alone in subjects with metastatic castration-resistant prostate cancer (mCRPC) – volume: 94 start-page: 8485 year: 1997 ident: bib39 article-title: Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF – volume: 101 start-page: 4758 year: 2004 ident: bib52 article-title: Structural basis of androgen receptor binding to selective androgen response elements – volume: 6 year: 2017 ident: bib10 article-title: Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer – volume: 30 start-page: 1380 year: 2021 ident: bib1 article-title: DNA-binding domain as the minimal region driving RNA-dependent liquid-liquid phase separation of androgen receptor – volume: 277 start-page: 41247 year: 2002b ident: bib48 article-title: The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF – volume: 30 start-page: 1958 year: 2023 ident: bib5 article-title: Rational optimization of a transcription factor activation domain inhibitor – volume: 13 start-page: 6390 year: 2022 ident: bib69 article-title: Small molecules targeting the disordered transactivation domain of the androgen receptor induce the formation of collapsed helical states – volume: 26 start-page: 145 year: 2018 ident: bib17 article-title: Regulation of androgen receptor activity by transient interactions of its transactivation domain with general transcription regulators – volume: 19 start-page: 26 year: 2001 ident: bib19 article-title: Intrinsically disordered protein – volume: 22 start-page: 570 year: 2023 ident: bib63 article-title: Discovery of a small-molecule inhibitor targeting the androgen receptor N-terminal domain for castration-resistant prostate cancer – volume: 43 start-page: 1701 year: 2023 ident: bib49 article-title: Current and emerging approaches to noncompetitive AR inhibition – volume: 66 start-page: 11158 year: 2023a ident: bib66 article-title: Discovery of BWA-522, a first-in-class and orally bioavailable PROTAC degrader of the androgen receptor targeting N-terminal domain for the treatment of prostate cancer – volume: 64 start-page: 11045 year: 2021 ident: bib26 article-title: Exploration and biological evaluation of basic heteromonocyclic propanamide derivatives as SARDs for the treatment of enzalutamide-resistant prostate cancer – volume: 110 start-page: 2361 year: 2016 ident: bib21 article-title: Sequence context influences the structure and aggregation behavior of a PolyQ tract – volume: 31 start-page: e4334 year: 2022 ident: bib53 article-title: Topological dynamics of an intrinsically disordered N-terminal domain of the human androgen receptor – volume: 25 year: 2022 ident: bib65 article-title: Spatial definition of the human progesterone receptor-B transcriptional complex – volume: 11 start-page: 2499 year: 2016 ident: bib16 article-title: EPI-001, A compound active against castration-resistant prostate cancer, targets transactivation unit 5 of the androgen receptor – volume: 17 start-page: 535 year: 2010 ident: bib2 article-title: Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor – volume: 352 start-page: 77 year: 1991 ident: bib54 article-title: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy – volume: 10 start-page: 33 year: 2004 ident: bib11 article-title: Molecular determinants of resistance to antiandrogen therapy – volume: 14 start-page: 1800 year: 2023 ident: bib27 article-title: Synthesis and evaluation of small molecule inhibitors of the androgen receptor N-terminal domain – volume: 169 start-page: 13 year: 2017 ident: bib29 article-title: A phase separation model for transcriptional control – volume: 278 start-page: 14956 year: 2003 ident: bib35 article-title: Identification of a highly conserved domain in the androgen receptor that suppresses the DNA-binding domain-DNA interactions – volume: 20 start-page: LBA016 year: 2021 ident: bib44 article-title: Androgen receptor (AR) abstract LBA016: androgen receptor (AR) N-Terminus-Domain-Binding small molecule degraders for the treatment of AR splice variant-positive castration-resistant prostate cancer – volume: 277 start-page: 20079 year: 2002a ident: bib47 article-title: Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions – volume: 18 start-page: 1341 year: 2022 ident: bib61 article-title: Targeting androgen receptor phase separation to overcome antiandrogen resistance – volume: 41 start-page: 301 year: 2008 ident: bib14 article-title: Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain – volume: 7 year: 2012 ident: bib24 article-title: The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity – volume: 120 start-page: 4312 year: 2021 ident: bib20 article-title: Metapredict: a fast, accurate, and easy-to-use predictor of consensus disorder and structure – volume: 72 start-page: 19 year: 2018 ident: bib8 article-title: Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments – volume: 18 start-page: 2132 year: 2004 ident: bib18 article-title: Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor – volume: 16 start-page: 663 year: 2014 ident: bib12 article-title: Insight into recent advances in degrading androgen receptor for castration-resistant prostate cancer – volume: 47 start-page: 3360 year: 2008 ident: bib33 article-title: Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding – volume: 266 start-page: 510 year: 1991 ident: bib51 article-title: Transcriptional activation and nuclear targeting signals of the human androgen receptor – year: 2021 ident: bib38 article-title: Androgen physiology: receptor and metabolic disorders |
| SSID | ssj0002872866 |
| Score | 2.2786531 |
| SecondaryResourceType | review_article |
| Snippet | Signalling by the steroid hormone testosterone involves the androgen receptor (AR), a structurally dynamic protein. The amino-terminal domain of the AR makes... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e240061 |
| SubjectTerms | androgen receptor endocrine therapy resistance prostate Review |
| Title | The androgen receptor amino-terminal domain: structure, function and therapeutic potential |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40051657 https://www.proquest.com/docview/3174822208 https://pubmed.ncbi.nlm.nih.gov/PMC11883864 https://doaj.org/article/187dc4330fb240849fddc75e75512cb9 |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8UwEA7iQbyIu3UjokeLTbM-bypPRFAvCuIlZCs-0fbh8v-daau8J4IXr11omG-amW8y-ULIgVGJmcKznBvngKAUJnfYJsZYSKxiqPKEdcira3VxJy7v5f3EUV_YE9bJA3eGO2JGxyCAdVce1bjEoIoxaJk0hPoy-HbrHsS8CTL11JaMdGmU6vVIJS-Ohjd5KXKM2FMRqBXq_y27_NkkORF1zhfJQp8u0pNumEtkJtXLZO6qXxBfIQ8AM3UoOgCOQGH2SmMg0dS9jOom7xtdnmlsXtyoPqadWOzHazqkGM8QE3yZTmzCouPmHRuI3PMquTsf3p5d5P1xCXkADsVyKbj2ceB04tJVInimo_RgcB0V_GkiVKXT0mvP3cAJx2GWVphvMBnKSkfN18hs3dRpg9BBgKAlZJVCJUXQpffBFyIUwkE6wKPKyP6XCe24U8WwyCbA0HZ4Y0th0dAZOUXrfj-BStbtBcDX9vjav_DNyN4XNhY8H5czXJ2ajzcLmY_A9KYwGVnvsPr-lMDJRkmdETOF4tRYpu_Uo8dWXRsYl-FGic3_GP0WmS_xwOC2ZrNNZgHmtANZzLvfbR12ty0vfQIDE_G- |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+androgen+receptor+amino-terminal+domain%3A+structure%2C+function+and+therapeutic+potential&rft.jtitle=Endocrine+oncology&rft.au=Hunter%2C+Irene&rft.au=Jamieson%2C+Craig&rft.au=McEwan%2C+Iain+J&rft.date=2025-01-01&rft.eissn=2634-4793&rft.volume=5&rft.issue=1&rft.spage=e240061&rft_id=info:doi/10.1530%2FEO-24-0061&rft_id=info%3Apmid%2F40051657&rft.externalDocID=40051657 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2634-4793&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2634-4793&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2634-4793&client=summon |